1061 related articles for article (PubMed ID: 15308129)
1. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
2. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
3. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
[TBL] [Abstract][Full Text] [Related]
4. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
[TBL] [Abstract][Full Text] [Related]
5. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
[TBL] [Abstract][Full Text] [Related]
6. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy.
Ségalat L; Grisoni K; Archer J; Vargas C; Bertrand A; Anderson JE
Exp Cell Res; 2005 Jan; 302(2):170-9. PubMed ID: 15561099
[TBL] [Abstract][Full Text] [Related]
7. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
Wehling M; Spencer MJ; Tidball JG
J Cell Biol; 2001 Oct; 155(1):123-31. PubMed ID: 11581289
[TBL] [Abstract][Full Text] [Related]
8. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
9. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
Rafael JA; Brown SC
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963
[TBL] [Abstract][Full Text] [Related]
13. Talin, vinculin and nestin expression in orofacial muscles of dystrophin deficient mdx mice.
Spassov A; Gredes T; Pavlovic D; Gedrange T; Lehmann C; Lucke S; Kunert-Keil C
Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):137-43. PubMed ID: 22307364
[TBL] [Abstract][Full Text] [Related]
14. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
15. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
[TBL] [Abstract][Full Text] [Related]
16. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
[TBL] [Abstract][Full Text] [Related]
18. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
Judge LM; Haraguchiln M; Chamberlain JS
J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
[TBL] [Abstract][Full Text] [Related]
20. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
Gillis JM
Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
